PET Detection of CCR2 in Human Atherosclerosis
NCT04537403
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
: Use of novel radio-pharmaceutical 64CUDOTA-ECL1i to evaluate arterial atherosclrosis
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Carotid Atherosclerosis
Eligibility basics and study details
- Study type
- Interventional
- Phase
- Phase 1
- Ages
- 18 to 89 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- Washington University School of Medicine
- Last updated on ClinicalTrials.gov
- August 1, 2025
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
Missouri · 1
- Washington University CCIR · St Louis, MO
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.